Please login to the form below

Not currently logged in
Email:
Password:

pixantrone

This page shows the latest pixantrone news and features for those working in and with pharma, biotech and healthcare.

CTI launches cancer drug Pixuvri in UK

CTI launches cancer drug Pixuvri in UK

Pixuvri (pixantrone) becomes the first drug available in the UK as a monotherapy treatment option for adults with multiply relapsed or refractory aggressive B-cell non-Hodgkin lymphoma.

Latest news

More from news
Approximately 3 fully matching, plus 5 partially matching documents found.

Latest from PMHub

  • Oncology drugs under AMNOG

    Pixuvri: Polycomparator segmentation by the G-BA removes statistical power. Cell Therapeutics gained European approval for Pixuvri (pixantrone) in non-Hodgkin’ s B-cell lymphoma, on the basis of a trial

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Lucid Group Communications Limited

We are industry-leading thinkers when it comes to education. We use the latest academic thinking on the psychology of behaviour...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics